Yoshikawa Katsuhiro, Chiba Tsukuru, Miyata Mami, Sueoka Noriko, Ishizuka Mariko, Yamamoto Daigo
Dept. of Surgery, Kansai Medical University.
Gan To Kagaku Ryoho. 2018 Dec;45(13):2096-2098.
In case an operation is necessary after an ST-VAB for microcalcification, a wide excision needs to be performed because of the loss of marking. The HydroMARK®breast biopsy marker can be visualized using an ultrasound or mammography and facilitates a small excision. Six months after the deployment, all markers were visualized using an ultrasound. Thus, Hydro MARK®can decrease the sample size(11 g)in open biopsies and correctly diagnose ADH. However, no HydroMARK®cases were diagnosed with ADH in large samples(44 g, 32 g). Five malignant histology cases underwent mastectomy, and the distance between the HydroMARK®and tumor was 300 mm. HydroMARK®appears to be a safe and effective marker after a stereotactic biopsy for calcification, which facilitates an exact small excision of lesion surgically.
如果在因微小钙化进行立体定位真空辅助活检（ST-VAB）后需要进行手术，由于标记物丢失，需要进行广泛切除。HydroMARK®乳腺活检标记物可通过超声或乳腺X线摄影显影，有助于进行小范围切除。植入后6个月，所有标记物均通过超声显影。因此，HydroMARK®可减少开放活检的样本量（11克）并正确诊断非典型导管增生（ADH）。然而，在大样本（44克、32克）中，没有HydroMARK®病例被诊断为ADH。5例恶性组织学病例接受了乳房切除术，HydroMARK®与肿瘤之间的距离为300毫米。HydroMARK®似乎是一种在钙化的立体定向活检后安全有效的标记物，有助于手术中精确地小范围切除病变。
